The pathophysiology underlying chronic kidney disease

Robert Lewis
{"title":"The pathophysiology underlying chronic kidney disease","authors":"Robert Lewis","doi":"10.3132/PCCJ.2009.028","DOIUrl":null,"url":null,"abstract":"1 mL/min/year after the age of 40 in otherwise healthy individuals. Figure 1 shows how this age-related decline leads the ‘normal’ GFR (accurately measured by isotopic means) for individuals over 70 years to fall into the range where the equivalent estimated GFR (eGFR, which is calculated from serum creatinine, using a formula) would be compatible with a diagnosis of chronic kidney disease (CKD). This is why there is still debate about the implications of a low eGFR in the elderly. In certain individuals, however, glomerulosclerosis occurs either prematurely or more rapidly than expected as a consequence of systemic vascular disease. These individuals are then identified as having CKD. Glomerulosclerosis T he glomerulus is essentially a knot of blood vessels and there are about a million of them in each kidney. Appreciating that the kidneys are highly vascular organs is the key to understanding why their function is affected by systemic vascular damage, such as that due to hypertension, atheroma or diabetes. It also explains why they are a good place to look for evidence of early disease when assessing the overall health of a patient’s vasculature and their risk of future cardiovascular events. Glomeruli lose their function as part of the normal ageing process and healthy tissue is replaced by scar tissue. This process, known as glomerulosclerosis, causes the glomerular filtration rate (GFR) to fall by approximately Once started, CKD becomes a selfperpetuating condition (Figure 2). Initial reduction in the number of nephrons by whatever mechanism (for the purposes of this discussion, glomerulosclerosis caused by systemic vascular disease) leads to structural and functional changes in surviving nephrons. These changes are mediated by vasoactive molecules, notably the renin-angiotensin system (RAS), cytokines, and growth factors. Initially, the kidneys increase capillary flow to non-sclerosed glomeruli in an effort to maintain GFR. But this state of ‘hyperfiltration’ eventually causes intraglomerular hypertension and accelerated sclerosis of remaining nephrons. As the nephrons sclerose, the demands placed on surviving nephrons increase, accelerating their sclerosis in turn. DISEASE REVIEW","PeriodicalId":308856,"journal":{"name":"Primary Care Cardiovascular Journal (pccj)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Primary Care Cardiovascular Journal (pccj)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3132/PCCJ.2009.028","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

1 mL/min/year after the age of 40 in otherwise healthy individuals. Figure 1 shows how this age-related decline leads the ‘normal’ GFR (accurately measured by isotopic means) for individuals over 70 years to fall into the range where the equivalent estimated GFR (eGFR, which is calculated from serum creatinine, using a formula) would be compatible with a diagnosis of chronic kidney disease (CKD). This is why there is still debate about the implications of a low eGFR in the elderly. In certain individuals, however, glomerulosclerosis occurs either prematurely or more rapidly than expected as a consequence of systemic vascular disease. These individuals are then identified as having CKD. Glomerulosclerosis T he glomerulus is essentially a knot of blood vessels and there are about a million of them in each kidney. Appreciating that the kidneys are highly vascular organs is the key to understanding why their function is affected by systemic vascular damage, such as that due to hypertension, atheroma or diabetes. It also explains why they are a good place to look for evidence of early disease when assessing the overall health of a patient’s vasculature and their risk of future cardiovascular events. Glomeruli lose their function as part of the normal ageing process and healthy tissue is replaced by scar tissue. This process, known as glomerulosclerosis, causes the glomerular filtration rate (GFR) to fall by approximately Once started, CKD becomes a selfperpetuating condition (Figure 2). Initial reduction in the number of nephrons by whatever mechanism (for the purposes of this discussion, glomerulosclerosis caused by systemic vascular disease) leads to structural and functional changes in surviving nephrons. These changes are mediated by vasoactive molecules, notably the renin-angiotensin system (RAS), cytokines, and growth factors. Initially, the kidneys increase capillary flow to non-sclerosed glomeruli in an effort to maintain GFR. But this state of ‘hyperfiltration’ eventually causes intraglomerular hypertension and accelerated sclerosis of remaining nephrons. As the nephrons sclerose, the demands placed on surviving nephrons increase, accelerating their sclerosis in turn. DISEASE REVIEW
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
慢性肾脏疾病的病理生理学
40岁以后1 mL/min/年,其他健康个体。图1显示了这种与年龄相关的下降如何导致70岁以上个体的“正常”GFR(通过同位素方法精确测量)落入等效估计GFR (eGFR,使用公式从血清肌酐计算)与慢性肾脏疾病(CKD)诊断相容的范围。这就是为什么对于低eGFR对老年人的影响仍然存在争论。然而,在某些个体中,作为全身性血管疾病的后果,肾小球硬化要么发生得过早,要么发生得比预期更快。这些人随后被确定为CKD患者。肾小球硬化肾小球本质上是一个血管结,每个肾脏中大约有一百万个肾小球。认识到肾脏是高度血管化的器官,是理解为什么肾脏的功能会受到全身血管损伤(如高血压、动脉粥样硬化或糖尿病)影响的关键。这也解释了为什么在评估患者血管系统的整体健康状况和未来心血管事件的风险时,它们是寻找早期疾病证据的好地方。作为正常衰老过程的一部分,肾小球失去了功能,健康组织被疤痕组织所取代。这一过程被称为肾小球硬化,导致肾小球滤过率(GFR)下降大约。一旦开始,CKD就会成为一种自我延续的疾病(图2)。无论出于何种机制(本讨论的目的是由系统性血管疾病引起的肾小球硬化),肾脏单位数量的初始减少都会导致存活的肾单位的结构和功能改变。这些变化是由血管活性分子介导的,特别是肾素-血管紧张素系统(RAS)、细胞因子和生长因子。最初,肾脏增加非硬化肾小球的毛细血管流量以维持GFR。但这种“超滤过”状态最终导致肾小球内高血压和剩余肾单位加速硬化。随着肾单位的硬化,对存活的肾单位的需求增加,反过来加速了它们的硬化。疾病检查
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Statin prescribing in Europe: A comparison of differences and potential impact on health outcomes Atrial fibrillation: which patients should be managed in primary, secondary and tertiary care? How well are we doing in lipid management Assessing cardiovascular risk in the 10-minute consultation Smoking cessation 1: Choosing the right pharmacotherapy for each patient
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1